Filter by: patients
Home > Community Treatment Reports and Side Effects > Pyridostigmine Treatment Report
What is Pyridostigmine?

Pyridostigmine is an acetylcholinesterase inhibitor used for the symptomatic treatment of myaesthenia gravis and as an antidote for nondepolarizing neuromuscular blockers.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Myasthenia Gravis 25 6 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Other 10 3 Efficacy_major Efficacy_moderate Efficacy_slight
Fatigue 6 2 Efficacy_moderate Efficacy_none
ALS (Amyotrophic Lateral Sclerosis) 4 0
Lambert-Eaton Myasthenic Syndrome 3 0
Dysautonomia 2 1 Efficacy_slight

See all 45 patients currently taking Pyridostigmine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 5
Mild
 3
None
 7

Commonly reported side effects, conditions, and hospitalizations associated with Pyridostigmine

Diarrhea 2
Nausea 1
Memory problems 1
Muscle twitching (fasciculations) 1
Woozy 1
Excessive tearing eyes 1
See all 8 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Pyridostigmine. See all 19 dosages ►

  60mg as needed 60 mg daily 80 mg daily 90 mg daily 120 mg daily 180 mg daily 240 mg daily 300 mg daily 360 mg daily 480 mg daily
  2 Number of Patients: 2 8 Number of Patients: 8 1 Number of Patients: 1 5 Number of Patients: 5 8 Number of Patients: 8 7 Number of Patients: 7 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Pyridostigmine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 8   Did not seem to work: 50%
Doctor's advice 5   Doctor's advice: 31%
Side effects too severe 3   Side effects too severe: 19%
Other 3   Other: 19%
Course of treatment ended 1   Course of treatment ended: 6%

See all 15 patients who’ve stopped taking Pyridostigmine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Pyridostigmine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Pyridostigmine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Pyridostigmine

Always
 9 60%
Usually
 5 33%
Sometimes
 1 7%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Pyridostigmine

Very
 0 0%
Somewhat
 1 7%
A little
 5 33%
Not at all
 9 60%

Cost

Paid out of pocket

Cost of Pyridostigmine

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 17%
$25-49
 3 50%
< $25
 2 33%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.